Tech StocksTech stocks in the healthcare industry are skyrocketing through the pandemic of coronavirus. Take a look.

Things are moving very quickly in terms of how the healthcare industry is changing, and getting in tune with the businesses that are driving innovation could lead to strong performance for your portfolio. Adding shares of companies that are disrupting the industry and are nicely poised to outperform over the long term could be a very prudent move. Healthcare tech stocks have underperformed the S&P 500 in 2021, but analysts are optimistic that a handful of top healthcare names are positioned for a big year in 2022. Stocks exposed to the ongoing pandemic will experience more tail winds in the next couple of quarters, but the healthcare industry is expected to continue to normalize. This article lists the top tech stocks in the healthcare industry for 2022. 

Bio-Rad Laboratories, Inc.

Current Price: US$587.40

Market Cap: US$17.6 Billion 

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

SAGE Therapeutics, Inc. 

Current Price: US$38.82 

Market Cap: US$2.3 Billion 

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous systems. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for the treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010, and is headquartered in Cambridge, MA.

Organon & Co.

Current Price: US$31.82

Market Cap: US$8.1 Billion 

Organon & Co. is a science-based global pharmaceutical company that develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars, and established brands. The company was founded on March 11, 2020 and is headquartered in Jersey City, NJ.

Pfizer Inc

Current Price: US$54.05

Market Cap: US$303.4 Billion 

Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales, and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Royalty Pharma Plc

Current Price: US$39.31

Market Cap: US$16.8 Billion 

Royalty Pharma Plc provides drug development services. The firm operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

QIAGEN NV

Current Price: US$49.57

Market Cap: US$11.3 Billion 

QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

HCA Healthcare, Inc.

Current Price: US$240.76 

Market Cap: US$74.9 Billion 

HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, as well as diagnostic and emergency services. The company was founded by Dr. Thomas Frist, Sr., Dr. Thomas Frist, Jr., and Jack Massey in 1968 and is headquartered in Nashville, TN.